250 ML dopamine hydrochloride 0.8 MG/ML Injection — RxCUI 1743869
RxNorm drug concept · Semantic clinical drug
RxCUI 1743869
Semantic clinical drug · SCD
● Current RxNorm concept 3 FDA products
5 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1743869
Official name250 ML dopamine hydrochloride 0.8 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdopamine HCl 800 MCG/ML per 250 ML Injection; DOPamine HCl 800 MCG/ML in 250 ML Injection
FDA products mapped3
Package NDCs mapped5
Reported Medicaid activity (SDUD)246 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Dopamine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's an IV medicine for shock, when blood pressure and blood flow are dangerously low. That can happen after a heart attack, trauma, severe infection, open-heart surgery, kidney fa...
- Only through an IV, usually in a hospital and often with an infusion pump. The care team adjusts the rate based on how you respond. You won't take it at home.
- Possible effects include nausea, vomiting, headache, anxiety, a pounding heartbeat, chest pain, shortness of breath and high blood pressure. Tell your nurse about any of these. Rep...
- If dopamine leaks out of the vein, it can seriously damage the surrounding tissue. That's why it goes into a large vein and the site is checked often. Speak up right away if it hur...
🕸️ Concept Web — How 250 ML dopamine hydrochloride 0.8 MG/ML Injectio... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
250 ML dopamine hydrochloride 0.8 MG/ML Injection
RxCUI 1743869 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Dopamine
3628IN -
Dopamine hydrochloride
82010PIN
-
Dopamine
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Dopamine Injection
1743862SCDF -
Dopamine hydrochloride Injection
2648559SCDFP -
Dopamine Injectable Product
1160755SCDG -
Dopamine hydrochloride Injectable Product
2662270SCDGP -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Dopamine Injection
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Dopamine hydrochloride 0.8 MG/ML
1292739SCDC
-
Dopamine hydrochloride 0.8 MG/ML
Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Dopamine hydrochloride 0.8 MG/ML
SCDC · 1292739 -
Dopamine Injection
SCDF · 1743862 -
Dopamine hydrochloride Injection
SCDFP · 2648559 -
Dopamine Injectable Product
SCDG · 1160755 -
Dopamine hydrochloride Injectable Product
SCDGP · 2662270
📦 FDA Products & Package NDCs
3 products · 5 package NDCs
5 package NDCs map to RxCUI 1743869 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00338-1005-02 | 18 BAG in 1 CARTON (0338-1005-02) / 250 mL in 1 BAG | Dopamine Hydrochloride and Dextrose | Baxter Healthcare Corporation | 1987-03-27 |
| 00338-1005-03 | 12 BAG in 1 CARTON (0338-1005-03) / 500 mL in 1 BAG | Dopamine Hydrochloride and Dextrose | Baxter Healthcare Corporation | 1987-03-27 |
| 00338-1007-02 | 18 BAG in 1 CARTON (0338-1007-02) / 250 mL in 1 BAG | Dopamine Hydrochloride and Dextrose | Baxter Healthcare Corporation | 1987-03-27 |
| 00338-1007-03 | 12 BAG in 1 CARTON (0338-1007-03) / 500 mL in 1 BAG | Dopamine Hydrochloride and Dextrose | Baxter Healthcare Corporation | 1987-03-27 |
| 00338-1009-02 | 18 BAG in 1 CARTON (0338-1009-02) / 250 mL in 1 BAG | Dopamine Hydrochloride and Dextrose | Baxter Healthcare Corporation | 1987-03-27 |
Observed labelers:
Baxter Healthcare Corporation (5)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J1265 | Dopamine injection | 5 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.